Diacerein ointment (TWi Biotechnology)

双醋瑞因软膏(TWi Biotechnology)

Report date: 2025/12/01 17:19:15

Base Information

Drug NameDiacerein ointment (TWi Biotechnology)
Drug Alias NameAC-203 1% Topical OintmentAC-203 1% ointment BIDAC-203
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-1 beta inhibitors
TargetsInterleukin-1 beta
Therapy Area/IndicationsPemphigoid, BullousEpidermolysis Bullosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwanMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTwi Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesTwi Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsEpidermolysis Bullosa
Inactive IndicationsPemphigoid, Bullous

Other Information

ATC CodeN/A
Related LinksN/A